当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2008年第31期
编号:11702691
美他多辛治疗酒精性脂肪肝的临床观察
http://www.100md.com 2008年11月5日 赵 巍 程春艳 杨 光
第1页

    参见附件(265KB,2页)。

     [摘要] 目的:观察美他多辛治疗酒精性脂肪肝的临床疗效。方法:将酒精性脂肪肝患者68例随机分为两组,观察组38例给予美他多辛片500 mg,每日2次口服;对照组30例给予甘利欣片150 mg,每日3次口服,疗程均为3个月。结果:美他多辛治疗酒精性脂肪肝可明显改善患者的临床症状,总有效率为94.7%,与对照组相比有显著性差异(P<0.05)。结论:美他多辛可有效改善酒精性脂肪肝患者的临床症状和肝功能,可降低血脂,且无严重不良反应,值得临床推广。

    [关键词] 美他多辛;酒精性脂肪肝

    [中图分类号] R575.5[文献标识码]C [文章编号]1673-7210(2008)11(a)-057-02

    Clinical investigation on treatment of alcoholic fatty liver with Metadoxine ZHAO Wei1,CHENG Chun-yan2,YANG Guang1

    (1.Department of Digestion, Harbin First Hospital, Harbin150010,China; 2.Heilongjiang Forest Industry General Hospital, Harbin150010, China)

    [Abstract] Objective: To observe the clinical effect of alcoholic fatty liver with Metadoxine. Methods: Alcoholic fatty liver patients were randomly divided into two groups of 68 cases, 38 cases suffering from alcoholic fatty liver were treated with Metadoxine tablets 500 mg bid po, and 30 cases in control group were treated with DiammoniumGlycyrrhizinate tablets 150 mg tid po in 3 months of treatment ......

您现在查看是摘要介绍页,详见PDF附件(265KB,2页)